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The function of a carboxyl-terminal truncated version of the Xenopws aetivin receptor, encoded by a previously isolated gene XSTK2, was 
investigated in early embryos. The transcript correspondin~ to the truncated receptor gene was detected throughout embryonic development 
although the temporal expression pattern was different from that of n intact receptor. Injection of XSTK2 mRNA into early embryos resulted 
in the formation f a duplicated body axis. Mesoderm induction as evaluated by the activation f the rr.actin gone i  presumptive ectoderm (animal 
cap) treated with exogenous activin was significantly enhanced by the injection of XSTK2 mRNA. These results suggest that he truncated receptor 
is capable of transmitting the activin signal to the same ¢~ttent as the native receptor. 
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1. INTRODUCTION 
Activin, a member of the TQF-/~ superfamily, is 
known to function not only as a regulator of hormone 
secretion [1,2] but also as a regulator of cell differentia- 
tion for a variety of cell types [3-5]. It has been demon- 
strated by affinity cross-linking that there are three mo- 
lecular species of the activin receptor in routine 
erythroleukemia F5-5 cells and these have been desig- 
nated as type I (42 kDa), type II (51 kDa) and type III 
(151 kDa) [6]. Recently, the structure of a mouse activin 
receptor has been investigated by gene cloning [7]. 
Based on the molecular weight predicted from the 
eDNA, the receptor was classified as a type II receptor. 
Furthermore, the type II receptor for TGF-fll has also 
been cloned [8]. All the so far characterized type II 
receptors appear to possess protein Ser/Thr kinases in 
their cytoplasmic domains [9]. 
Similar activin receptor genes have previously been 
isolated from amphibian sources and these have been 
shown to be involved in morphogenesis during early 
development [I0,11], We have previously reported that 
there are at least four genes that encode activin recep- 
tor-like proteins in Xenopus laevis [12]. One gene was 
found to encode a receptor protein which lacks the car- 
boxyl-terminal part of  the Ser/Thr kinase located istal 
to domain VIII. We reasoned that the truncated recep- 
tor might represent a protein which plays a negative 
regulatory role in activin signaling. The present study 
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was carried out in order to examine whether or not the 
truncated activin receptor was capable of correctly 
transmitting the activin signal. Here we report that the 
truncated receptor is functional and able to cause dupli- 
cation of the partial body axis as well as enhancement 
of mesoderm induction to the same extent as the intact 
receptor. 
2. MATERIALS AND METHODS 
2.1. Reverse transcrtption-PCR (RT-PCR) 
In order to distinguish transcripts of he XgTK2 gene from those 
of the XSTK3 and XSTK8 genes, whose nueleotide sequences ar  
highly similar to XSTK2 in the N.terminal region [12], RT-PCR was 
performed as described [13,14]. The sequences ofthe various oligonu- 
cleotide primers used are as follows. The upper strand primer se- 
quence, 5'-GAAACAATGGCTCGTGGGC-3', is located in a region 
in common to the XSTK2, XSTK3 and XSTK8 gen~ whereas the 
lower strand prlmer sequences, 5'-TCGCTGCACAAGTGATTACC- 
3' and 5'-CTCTAGAACCTCAGGAGCC-3', were chosen from re. 
gions specific to the XSTK2 and XgTK3/8 genes, re'spectively. The 
conditions used for PCR were as follows. Denaturation was per- 
formed at 94"C for 30 s followed by ann~ling at 60"C for 30 s with 
the subsequent extension reaction carried out t 72°C for 60 s. A total 
number of 30 reaction cycles were performed in the presence of 
[~-a2P]dCTP (Amersham). Template cDNA wa-~ synthesized with the 
use of MMLV reverse transeriptase (BRL) fromtotal RNA purified 
from staged embryos by the AGPC method [15]. The PIER products 
were separated on 0.2 mm-thick polyacrylamide gels, which were t en 
dried for autoradiograph~,. For quantitation f muscle specific rr-actin 
mRNA, we rever~ transcribed total RNA isolated from animal cap 
¢xplants and performed a PCR as previously described by Rupp et al. 
[16], 
2.2. bz vitro transcription attd translatioll 
Capped synlhe, tic RNAs were gener-,ted as escribed [17]. The inserts 
of the Xenopus activin receptor clones XSTK2 (SaclllXhol in~ert of 
0.7 Kb) and XSTK8 (RamHl/Xhol inert of l.SKb) were subeloned 
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into a pSP73polyA w.'ctor which was constructed by the insertion of
a 83 bp l~coRi/HindlIl fi..agment containln~ a polyA tract and multiple 
cloning site region from pSP64polyA (Promega) into pSP73. The 
pSP73polyA based constructs were transcribed with T7 RNA poiym- 
erase in vitro. Each synthetic RNA was translated in a rabbit reticulo- 
cyte lysate (Promega) in the presence of [~SS]methionin¢ (Amersham) 
and analyzed by SDS.PAGE. 
2.3. Injection of mRNAs 
Mieroinjection of receptor mRNAs, performed in order to study 
phenotypic alterations, was carried out essentially a  described by 
Yage et al. [18]. Briefly, mRNA~ were injected into ventral blastomers 
of 4..c¢11 embryos in Steinberg's solution after emoval of the vitellin¢ 
membrane. The embryos were then allowed to develop i~ the same 
solution for several days during the period of the experiment• For the 
mesoderm induction assay, injections were carried outaccording to 
the method of Moon et al. [19] in 5% Ficoll. 
2.4. Animal cap assay 
The animal cap assay using embryos injected with activin receptor 
mRNA was carried out as previously described [20].
3. RESULTS AND DISCUSSION 
As previously reported, extensive screening of a Zen- 
opus embryo eDNA library with mouse activin receptor 
eDNA [7] identified several activin receptor clones [12]. 
Interestingly, one of the clones designated as XSTK2 
was found to encode a highly similar protein to that of  
intact receptors encoded by XSTK3 and XSTK8 but  
lacking the carboxyl-terminal part o f  the Ser/Thr kinase 
region located on the C-terminal side of  domain V I I I  
(Fig. 1A). The nucleotide sequence of  XSTK2 contains 
a polyadenylat ion signal, AATAAA,  followed by a 
polyA tract in the Y-untranslated region consistent with 
the observat ion that the XSTK2 gene is transcribed. In 
our previous study, we have shown by Northern blot 
analysis that the XSTK2 and XSTK3 genes are tran- 
scribed in early embryos. However, we were unable to 
distinguish transcripts of  XSTK2 from those of XSTK3 
and XSTK8 since the probe was chosen f rom a region 
in common to the three receptor genes. In order to 
distinguish transcripts of XSTK2 from those of closely 
related intact receptor genes, oligonucleotide pr imer 
sets, each of  which was specific to XSTK2 or  XSTK 3/8, 
were designed (Fig. I B), Using the respective pr imer 
sets, the transcript levels during early development were 
examined by RT-PCR.  Fig. 2 shows an autorad iogram 
of  the PCR products from XSTK2 and XSTK3/8. These 
products were of  the expected size, viz. an XSTK2 prod-  
uct o f  219 b.p. and the XSTK3/8 products of  242 b.p. 
It is evident that all genes are transcribed uring early 
development. The transcript of  XSTK2 appeared to in- 
crease as development proceed, whereas that of the in- 
tact receptor (XSTK3/8) appeared to fluctuate during 
early embryogenesis (Fig. 2) thus suggesting that the 
gone for .,-,.,, . . . . . . . . . .  , ..,, .,~,~'4 receptor is ind,~p,;n,~ntly regu- 
lated f rom that o f  the intact receptor gone. The tempo-  
ral expression pattern of XSTK3/8 was consistent with 
our previous results obtained by Northern blott ing [12]. 
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Fig. 1. Structure ofthe truncated aetivin r~'cptor eDNA, XSTK2, and 
the deduced precursor proteia. (A) The nucleotide sequence of the 
full-length XSTK2 eDNA clone is shown along with the deduced 
amino acid sequence of the putative receptor protein. Tl~e sign.'d so. 
quence and the transmembrane domain are highlighted by thin under- 
lining. The sequences used to synthesize oligonucleotide primers for 
RT-PCR are indicated by wavy underlining. The putative polyadenyl- 
ation site at the 3' end of the mRNA is denoted by double underlining. 
The Ser/rhr kinase domain is shown by shading of the amino acid 
sequence. Roman numerals under the deduced amino acid sequence 
refer to subdomains conserved among the various members of the 
protein kinase family, (B) Schematic representation of Xenopus aetivin 
receptor proteins. The extraeellular domain, transmembrane region 
(shaded), SerfThr kinase domain and Ser/Thr rich domains are shown. 
Two characteristic in~erts in the kina~e domain are shaded [9]. The 
locations of the PCR primers are indicated by arrows and the pre- 
dicted sizes of amplified products are also shown. 
It was reasoned that the . . . .  J . . . . .  -u.c,,~e,+ recev,u, is capable 
of  binding activin since a mouse activin receptor with 
an even larger carboxyl-terminal deletion has been ob- 
served to bind activin in a similar fashion to the intact 
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- -  219  b ,p .  
mrw:~/s I i  I I  ~ llI I -~42~.p. 
Fig. 2. RT-PCR annie, sis of the truncated and intact activin receptor 
mRNA during early development. 500 ng of total RNA from staged 
embryos was subjected to RT.PCR using specific 3' reverse primers 
for truncated type (XSTK2) and intact tyl:m (X$TK3/8) re~ptor 
cDNAs, The upper strand primer lies in a region in common among 
the three receptor types. The transcript of EF-I~ was amplified in a 
similar fashion in order to analyze both the quality nd quantity of 
RNA (data not shown). 
receptor [7]. Therefore, we speculated that the truncated 
receptor encoded by XSTK2 could bind activin but was 
not able to transmit activin signals because of  the im- 
paired kinase domain. In order to examine this hypoth- 
esis we looked at the el'feet o f  overexpression f both the 
truncated and intact receptor proteins. We employed 
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Fig. 4. Developmental defeem in ombryos injected with activin recep- 
tor XSTK2 and XSTK8 mRNAs. Embryos were inj~ted at the 4-cell 
stag~ with mRNA synthesized in vitro (900 P8 mRNA/embryo). (A) 
represents an embryo injected with XSTK8 mRNA and (B) represents 
an embryo injected with XSTK2 mRNA. A control embryo injected 
witl~ buffer alone is shown in (C). 
32.5 -  
Fig. 3. In vitro synthesis o/" Xanopus aetivin receptor protein. The 
produc~s produced by a nuelease-treated rabbit reticulocyte lysate 
were loaded onto a 10% SDS-PAOE. Lysate containing XSTK8 
mRNA (lane 1), XSTK2 mRNA (lane 2) and lysate with no added 
RNA (lane 3). Mol~ular weight standards arc indicated in kDa on 
the leR. 
the strategy of  injecting XSTK2 mRNA into early em- 
bryos since it has been previously demonstrated that 
injection of  intact activin receptor mRNA results in 
duplication of  the body axis [10,11] and an increased 
level of  responsiveness ofanimal cap explants to activin 
[11 ]. To ascertain the molecular weight of  receptor pro- 
teins that would be translated by injected mRNAs,  we 
first translated these mRNAs  using a rabbit  reticuloeyte 
lysate (Fig. 3). The addition of  XSTK2 mRNA to the 
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FiB, 5. Induction ofthe ~-actin 8ene by activin in animal gaps isolated 
from embryos, Embryos were injected at the 4-cell stage with receptor 
XSTK2 and XSTK8 mRNAs synthesized in vitro (400 pg RNA/ 
embryo). Embryos were then allowed to develop to the blastula stage 
and animal caps obtained from five blastulae were incubated in the 
presence of various concentrations ofactivin for 1 day and pooled for 
the isolation of RNA. The relative expression of g-aetin mRNA in 
animal caps injected with XSTK8 and XSTK2 mRNA is represented 
by the hatched box and the shaded box respectively. Control embryos 
injected with buffer alon~ are shown by the open box. 
lysate resulted in the synthesis of a protein with an 
apparent molecular weight of 46 kDa (Fig. 3, lane 2) 
which is close to the molecular weight predicted from 
the eDNA structure as shown in Fig. 1. On the other 
hand, the molecular weight of the protein translated 
from intact receptor gene, XSTKg, was estimated to be 
64 kDa (Fig. 3, lane 1) representing the deletion of 
approximately 120 amino acids at the C-termi~ml end of 
XSTK2.  Fig. 4 shows typical phenotypic defects of em- 
bryos which were injected with various receptor 
mRNAs .  The result of this experiment was surprising 
in that overexpression f the carboxyl-terminal trun- 
cated receptor lead to significant alterations in normal 
development with the production of a duplicated body 
axis in a similar fashion to the effects demonstrated with 
intact activin receptors [10,1 l] (Fig. 4B). The frequency 
of the malformation i duced by XSTK2 overexpression 
was approximately 13% and this percentage is compara- 
ble to that produced by the injection of the intact recep- 
tor, XSTKg, used in the present s udy (Table I) and to 
that of xActRIB as reported by Mathews et al. [11]. In 
contrast o the effect observed with Xwtn.8, a gene 
which induces complete body axis formation [21,22], the 
additional body axis formed by injection of XSTK2 
mRNA is incomplete (Fig, 4A en B) and occurs par- 
tially along the antero-posterior axis. It is interesting to 
note that such a bifurcation produced by the truncated 
receptor occurs exclusively in the posterior region which 
includes the tail while overexpression f the intact re- 
ceptor often results in duplication of the anterior egion. 
Next, we examined the effect of overexpression f the 
truncated receptor on the competence of animal cap 
cells to respond to exogenous activin. It is well known 
that the animal cap of the blastula can respond to ex- 
ogenous aetivin. It is well known that the animal cap of 
the blastula can respond to activin and thereby differen- 
tiate into mesodermal derivatives [20,23]. This differen- 
tiation is associated with the activation of mesodermal 
marker genes uch as MyoD [16] and the muscle specific 
~-actin gene [24]. When animal caps isolated from em- 
bryos injected with XSTK2 or XSTK8 mRNAs were 
tested for ¢t-actin induction, they all demonstrated a 
significant increase of ~-actin mRNA as compared to 
animal caps from control embryos (Fig. 5). This indue- 
tion was increase approximately 3-fold by overexpres- 
sion of the intact receptor and 5-fold by the truncated 
receptor. These results suggest hat truncation of the 
carboxyl-terminus causes an increase in the intrinsic 
activity of the receptor. This increase in activity may be 
explained by the deletion of a regulatory region, such 
Table I
Defects produced in embryos injected with Xenopus activin receptor RNAs. Embryos with extra-dorsal structures laterally or ventrally placed were 
classified intt., several groups based on ppearance, viz. normal, no defect, short, short embryo length; anterior, duplicated head structures; posterior, 
extra tail- and trunk-llke protr~ions; pina bilida, bifurcation at posterior end. Controls with injected ooeyte mRNA and with no injected RNA 
arc presented for comparison, 
RNA injc.~ted Total 
(pg/embryo) (n) 
Embryos with phenotype (%) 





500 66 68 5 0 17 11 
900 47 72 0 4 13 6 
500 63 78 2 0 14 6 
900 42 90 0 0 7 2 
9O0 12 92 0 0 0 8 
26 88 0 0 0 11 
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as an autophosphorylation site(s), which may attenuate 
receptor kinase activity. This is consistent with observa- 
tions relating to the c- erbB-2 gene in that the lack of 
an autohosphorylation site located close to the car- 
boxyl-terrninus enhances the kinase and transforming 
activities of ErbB-2 [25]. 
In summary, the present study of the effects of recep- 
tor overexpression on morphogenesis and ~-actin gene 
activation suggests that the truncated activin receptor 
can mediate activin signals and function in a similar 
manner to the intact receptor. Precise investigations fo- 
cusing on structural-functional relationships of the ac- 
tivin receptor are necessary in order to determine the 
active core of the Ser/Thr kinas¢ and to correlate ato- 
phosphorylation of the receptor with various biological 
phenomena. 
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